Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?

Daniel S. K. Liu; Mireia Mato Prado; Elisa Giovannetti; Long R. Jiao; Jonathan Krell; Adam E. Frampton

doi:https://doi.org/10.1080/14737159.2019.1622414

Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?

Daniel S. K. Liu, Mireia Mato Prado, Elisa Giovannetti, Long R. Jiao, Jonathan Krell, Adam E. Frampton

Research output: Contribution to journal › Editorial › Academic › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	553-558
Number of pages	6
Journal	Expert review of molecular diagnostics
Volume	19
Issue number	7
DOIs	https://doi.org/10.1080/14737159.2019.1622414
Publication status	Published - 3 Jul 2019

Keywords

Circulating tumor DNA (ctDNA)
KRAS
PDAC
biomarker
exosomes
pancreatic ductal adenocarcinoma
survival

Access to Document

https://doi.org/10.1080/14737159.2019.1622414

Cite this

@article{31e14f9ad24049bfbe219ddb4846d0b3,

title = "Can circulating tumor and exosomal nucleic acids act as biomarkers for pancreatic ductal adenocarcinoma?",

keywords = "Circulating tumor DNA (ctDNA), KRAS, PDAC, biomarker, exosomes, pancreatic ductal adenocarcinoma, survival",

author = "Liu, {Daniel S. K.} and {Mato Prado}, Mireia and Elisa Giovannetti and Jiao, {Long R.} and Jonathan Krell and Frampton, {Adam E.}",

year = "2019",

month = jul,

day = "3",

doi = "https://doi.org/10.1080/14737159.2019.1622414",

language = "English",

volume = "19",

pages = "553--558",

journal = "Expert review of molecular diagnostics",

issn = "1473-7159",